We know this is an unprecedented time for everyone and we especially recognize that this serious health crisis could bring new concerns and challenges. As we navigate the COVID-19 crisis, Novo Nordisk is focusing on three key priorities:
You can find some information about all this along with some of the commonly-asked questions we’re getting into our call center. Check back for updates.
And, depending on what
information you need, contact us at the numbers and websites below.
We’re here to help.
For general inquiries:
For our Diabetes Patient Assistance Program, affordability and NovoCare services: 1.844.NOVO4ME (844.668.6463) or visit NovoCare.com
For Rare Bleeding Disorder services, please visit NovoSecure.com
If you’re a healthcare professional: NovoMedLink is your source for
diabetes product samples and support during the Coronavirus outbreak.
For growth hormone, please contact your local representative.
During the global coronavirus outbreak, one of Novo Nordisk’s key priorities is to safeguard the continued supply of our lifesaving medicines to patients. We have ample supplies of medicines, including insulin, and we expect to be able to fulfill orders and replenish pharmacies in the US throughout this pandemic. However, because of periodic increases in demand, there may be times when your local pharmacy is temporarily out of stock of diabetes medicines. We are working with our distributors to ensure that there is enough inventory to fill prescriptions quickly. We encourage patients to plan ahead and know that it may take some extra time to get a prescription filled. There is no delay in obtaining growth hormone or medicines for rare bleeding disorders.
If you have an affordability challenge or an immediate need for insulin, please go to NovoCare.com for options that may be able to help.
If you have a Rare Bleeding Disorder and are looking for support,
please visit NovoSecure.com for options that may be appropriate
On April 1, 2020, Novo Nordisk in the US made a commitment to donate $500,000 to national relief organizations as well as to New York City/New Jersey/Philadelphia relief efforts, including Direct Relief, AmeriCares, the NYC Emergency COVID-19 Relief Fund, the New Jersey Pandemic Relief Fund and the Philadelphia COVID-19 Relief Fund. We are also supporting emergency assistance requests from our patient/advocacy organizations and our local communities to address basic needs of individuals and families. We’re also expanding our matching gifts program until June 1, 2020.
We also know that small businesses are significantly affected by this outbreak. To support that, we have temporarily suspended our standard contractual payment terms and we will be paying submitted invoices immediately for nearly 500 small and diverse companies working with Novo Nordisk across the United States.
For more about how we’re helping the patients and healthcare
professionals looking to us for help during this pandemic, read our press
release and hear from Doug Langa, Executive Vice President, North
America Operations and President of Novo Nordisk Inc. in the video
Q: What are you doing to help people afford their insulin during this pandemic?
A: We already have a number of programs to support people who can’t afford their insulin that we believe are quite relevant during COVID-19. At the same time, we recognize that there are many people who are losing their jobs and or their insurance. Beginning April 14, 2020, people with diabetes using our insulin who have lost health insurance coverage because of a change in job status due to COVID-19 will be eligible for enrollment in our Diabetes Patient Assistance Program (PAP) and receive insulin free-of-charge for 90 days. We are committed to making this available through the end of the year as we monitor how the pandemic continues to affect our nation. There are eligibility requirements, but we are making the process as quick and easy as possible.
Q: How does this enhanced patient assistance program work?
A: If someone is facing a loss of healthcare benefits, Novo Nordisk will not require documented proof of income to qualify. We will require documentation showing loss of healthcare benefits, such as through job termination notice or job status change, or notification that COBRA is being offered. And, in situations where required documentation is not quickly accessible and there is a risk of rationing, we have an Immediate Supply option available that may help by providing what amounts to a free, one-month supply (up to three vials or two packs of pens) for many.
Q: What happens after 90 days?
A: After the first 90-days, ongoing eligibility will be assessed including proof of Medicaid denial for coverage through the rest of the calendar year. We will contact the patient every 90 days to ensure no change in coverage/employment through the end of the year. Beyond the COVID-19 crisis, we will continue working with patients facing affordability challenges to identify potential long-term options from our existing affordability offerings into 2021.
Q: How does this program apply to people with diabetes using Medicare?
A: Our criteria and enrollment processes are not changing for Medicare patients. More on those criteria can be found on NovoCare.com
Additionally, starting April 1, Novo Nordisk removed a requirement that Medicare Part D patients pay $1,000 in out of pocket prescription drug expenses before becoming eligible to participate in the Novo Nordisk Diabetes PAP. This change will expand access for eligible Medicare Part D patients to receive their Novo Nordisk medication at no cost.
Q: Why do Medicare patients automatically get free medicine for the rest of the year, but others need to apply for Medicaid?
A: Medicare recipients are government beneficiaries. CMS requires that once someone using Medicare is enrolled in a patient assistance program, they automatically have to remain in it for the rest of the year. It’s a different situation for someone losing commercial insurance. Medicaid offers support that keeps medicine and overall healthcare costs low during this time.
Q: Are other Novo Nordisk medicines part of this expansion?
A: This is being used for lifesaving medicines like insulin. It does not apply to our GLP-1 or growth hormone medicines at this time. However, other affordability options are available for most of those medicines.
Q: How long will this program be in effect?
A: We will make this available through the end of the year as we monitor how the pandemic continues to affect our nation.
Q: How can I find out if I’m eligible and apply for patient assistance?
A: Complete information about every Novo Nordisk diabetes affordability option can be found on one website - NovoCare.com (or by calling us at 1.844.NOVO4ME) - and many eligible patients can get a solution for medicines they need in minutes.
Q: Do you expect supply issues based on the coronavirus?
A: Our warehouses have a full inventory of medicines, including insulin, to fulfill orders and replenish wholesalers and pharmacies through this pandemic. However, we are seeing an increase in demand and there may be times when someone cannot get their prescription right away because the pharmacy or local wholesaler distribution center is temporarily out of stock of diabetes medicines. We encourage patients to plan ahead and call their pharmacy to see if there are any delays. There is no delay in obtaining growth hormone or medications for rare bleeding disorders.
If you have an affordability challenge or an immediate need, we may be able to help. Please go to NovoCare.com.
If you have a Rare Bleeding Disorder and are looking for support, please visit NovoSecure.com for options that may be appropriate for you.
Q: Where do your products come from?
A: All our active ingredients are manufactured in Denmark. Some of those medicines – Victoza, Norditropin, Ozempic, Rybelsus and our hemophilia medicines – are filled and packaged in Denmark and shipped to the US. Other medicines – our insulins – are filled and packaged here in the US.
Q: Do you have any products coming from China?
A: Only our NovoPen Echo, a durable insulin delivery device, is manufactured in Tianjin, China.
Q: What if there is a shortage? What are your plans?
A: As the coronavirus situation worsens in the US, we will work closely with local and regional authorities to ensure our medicines get to the patients who needs them. We’re continually monitoring the public health situation and will adjust as necessary
Our warehouses have a full inventory of medicines, including insulin, to fulfill orders and replenish wholesalers and pharmacies through this pandemic, along with medicines in various production stages at our manufacturing plants. However, we are seeing an increase in demand and there may be times when someone cannot get their prescription right away because the pharmacy or local wholesaler distribution center is temporarily out of stock of diabetes medicines. We encourage patients to plan ahead and call their pharmacy to see if there are any delays. There is no delay in obtaining growth hormone or medicines for rare bleeding disorders.
If you have an affordability challenge or an immediate need, we may be able to help. Please go to NovoCare.com.
If you have a Rare Bleeding Disorder and are looking for support, please visit NovoSecure .com for options that may be appropriate for you.
Q: Are your products made with ingredients from China?
A: Our US products do not have any active ingredients from China.
Q: Should I take less medicine than usual?
A: No. Rationing or reducing the dose of your medication may cause dangerous health consequences for you. Continue taking your medicine exactly as your Health Care Provider has prescribed it and discuss with them any specific changes in dose or medication type. If you have an affordability challenge or an immediate need, we may be able to help. Please go to NovoCare.com or for rare bleeding disorders, NovoSecure.com.
Q: I want to get a 90-day supply for my medicine. How do I do that?
A: Contact your Healthcare Provider if you wish to increase the amount of medicine you receive per prescription. He or she may also have you contact your health insurance company to understand your options.
Q: How can I continue to fill my prescriptions while practicing social distancing?
A: Contact your health insurance company about getting your prescriptions delivered to your home. You can also check if your local pharmacy is offering home delivery or has a drive-thru window.
Q: What should I do to avoid running out of my medicine?
A: We encourage you to plan ahead. Order your refills as early as your health insurance company will allow—at least two weeks in advance, if possible. You may want to set up a reminder on your phone or calendar for this. While health insurance companies don’t normally pay for refills before they are due, an exception may be made considering coronavirus concerns. You can also check with your local pharmacy if they offer auto-refills.
Q: How can I get samples of my medication?
A: Product samples are provided to Healthcare Providers; please call your current provider and check if he/she has any available to provide you.
Q: What if I need more diabetes medicine and my HCP doesn’t have any samples?
A: We have options that may help you through our online resource center, NovoCare. Patients and caregivers can call us at 1.844.NOVO4ME (668.6463) or go to NovoCare.com. Physicians can also go to NovoMedLink to order samples directly.
Q: I’m having a hard time managing my disease in this new normal. What should I do?
A: Reach out and work more closely with your Healthcare Provider. They know your personal health history best and will be able to work with you on how you can best take care of your disease. If you have questions specific to a Novo Nordisk medicine, please call us at 1.800.727.6500.
Q: I’m a caregiver and I’m concerned about my family member during this time.
A: We encourage you to regularly check in with your loved one and have them contact their Healthcare Provider more regularly during this time.
For up-to-date information and updates about the novel coronavirus (COVID-19), Consumers and healthcare professionals can visit the Centers for Disease Control and Prevention (CDC) and the websites of your state’s health department. Disease-specific resources to help you manage through the pandemic can be found below. If you’re a patient with concerns or questions, please contact your physician or healthcare provider.
AACE “My Diabetes Emergency Plan” – This American Association of Clinical Endocrinologists website offers a convenient checklist that contains all of the essential items those with diabetes need to have readily available in the event of an emergency.
American Diabetes Association – Some information for people with Type 1 and Type 2 diabetes in managing their diabetes during this public health crisis
JDRF – The JDRF is providing information in the interest of helping members of the T1D community make informed decisions regarding their health and well-being.
TCOYD (Taking Control of Your Diabetes) – Addresses questions and provides resources for people with diabetes during the pandemic
NHF – Some health and wellness information to help the community make information decisions during this public health crisis.
HFA – The HFA COVID-19 page provides information and resources for the community around health and coverage during this public health crisis.
Coalition for Hemophilia B – This page includes medical news and resources, and practical recommendations for people with hemophilia.
ASH (American Society of Hematology) – This page includes information and resources for hematologists.